Nuvectis Pharma Inc (NVCT) Stock Analysis

Nuvectis Pharma Inc (NVCT) is a publicly traded company in the HEALTHCARE sector. It trades at $9.51, carries a market capitalization of $260.21M. This page summarizes the public market data, fundamentals, and frequently asked questions for NVCT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Nuvectis Pharma Inc currently has a Bullish sentiment score of 0.29.

About Nuvectis Pharma Inc

Nuvectis Pharma, Inc. (NVCT) is a biopharmaceutical company based in Fort Lee, New Jersey, specializing in the development of targeted small molecule therapies for cancer treatment. The company boasts a promising pipeline that utilizes cutting-edge drug discovery technologies, setting the stage for innovative solutions that aim to improve both the efficacy and tolerability of cancer therapies. With a strong commitment to precision medicine and scientific rigor, Nuvectis is well-positioned to ...

GNG Research Analysis

GNG Research scores Nuvectis Pharma Inc (NVCT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NVCT.

Frequently Asked Questions

Does NVCT pay dividends?

Nuvectis Pharma Inc (NVCT) does not currently pay a regular dividend.

What is NVCT's market cap?

Nuvectis Pharma Inc (NVCT) has a market capitalization of $260.21M with a current stock price of $9.51.